John Paulson Bausch Health Companies Inc. Transaction History
Paulson & Co. Inc.
- $2.8 Billion
- Q3 2025
A detailed history of John Paulson (Paulson & Co. Inc.) transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Paulson & Co. Inc. holds 70,755,869 shares of BHC stock, worth $444 Million. This represents 16.32% of its overall portfolio holdings.
Number of Shares
70,755,869
Previous 32,791,702
115.77%
Holding current value
$444 Million
Previous $218 Million
108.97%
% of portfolio
16.32%
Previous 11.35%
Shares
5 transactions
Others Institutions Holding BHC
# of Institutions
261Shares Held
242MCall Options Held
2.54MPut Options Held
6.46M-
Goldentree Asset Management LP New York, NY34.8MShares$219 Million23.74% of portfolio
-
Nomura Holdings Inc Tokyo, M015.7MShares$98.6 Million0.17% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$81.6 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$76.9 Million0.0% of portfolio
-
Royal Bank Of Canada Toronto, A610.5MShares$66 Million0.01% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.27B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...